Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer

International Seminars in Surgical Oncology

Volumn 2, Issue , 2005, Pages

  Krynyckyi, Borys R ^a   Shafir, Michail K ^b   Kim, Suk Chul ^a   Kim, Dong Wook ^a   Travis, Arlene ^a   Moadel, Renee M ^c   Kim, Chun K ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

BREAST CANCER; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; INTERMETHOD COMPARISON; LYMPHOSCINTIGRAPHY; MORBIDITY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURGICAL ANATOMY; SURGICAL TECHNIQUE;

EID: 27944450812     PISSN: 14777800     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-2-25     Document Type: Review

References (132)

1. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000, 88:608-614.
2. Roumen RM, Kuijt GP, Liem IH, van Beek MW: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001, 88:1639-1643.
3. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002, 183:23-27.
4. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002, 73:31-36.
5. Temple LK, Baron R, Cody HS, 3rd, Fey JV, Thaler HT, Borgen PI, Heerdt AS, Montgomery LL, Petrek JA, Van Zee KJ: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002, 9:654-662.
6. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002, 9:745-753.
7. Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 2002, 28:705-710.
8. Leidenius M, Leppanen E, Krogerus L, von Smitten K: Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003, 185:127-130.
9. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003, 29:341-350.
10. Blanchard DK, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003, 138:482-487; discussion 487-488.
11. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
12. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2003, 98:690-696.
13. Peintinger F, Reitsamer R, Stranzl H, Ralph G: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003, 89:648-652.
14. Baron RH, Fey JV, Borgen PI, Van Zee KJ: Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 2004, 31:691-698.
15. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK: Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004, 37:73-91.
16. Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH: Breast lymphedema after breast conserving treatment. Acta Oncol 2004, 43:551-557.
17. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ: Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004, 11:1018-1024.
18. Langer S, Guenther JM, Haigh PI, Difronzo LA: Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004, 70:881-885.
19. Luini A, Gatti G, Zurrida S, Galimberti V, Paganelli G, Naninato P, Caldarella P, Rotmensz N, Winnikow E, Viale G: The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat 2005, 89:69-74.
20. Ronka R, von Smitten K, Tasmuth T, Leidenius M: One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005, 14:28-36.
21. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW: Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005, 23:4312-4321.
22. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE: Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2005, [Epub ahead of print] DOI: 10.1007/s10549-005-9025-7
23. Arnaud S, Houvenaeghel G, Moutardier V, Butarelli M, Martino M, Tallet A, Braud AC, Jacquemier J, Julian-Reynier C, Brenot-Rossi I: Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 2004, 30:735-743.
24. Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S: Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 2005, 92:17-22.
25. Krag D, Ashikaga T: The design of trials comparing sentinel-node surgery and axillary resection. N Engl J Med 2003, 349:603-605.
26. Badwe RA, Thorat MA, Parmar VV: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
27. De Salvo GL, Del Bianco P, Zavagno G: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
28. Munster AM: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
29. McMasters KM: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
30. Veronesi U, Maisonneuve P: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
31. Krag D, Ashikaga T: Sentinel-node biopsy in breast cancer [letter]. N Engl J Med 2003, 349:1968-1971; author reply 1968-1971.
32. Singh Ranger G, Mokbel K: The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2003, 29:423-425.
33. Kern KA: Achieving the lowest false-negative rate in peritumoral breast lymphatic mapping: the oncologic search for the Holy Grail. Ann Surg Oncol 2003, 10:486-487.
34. Cody HS 3rd: Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 2003, 10:1131-1132.
35. McMasters KM: The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer. Ann Surg Oncol 2003, 10:1128-1130.
36. Rutgers EJ: Sentinel node procedure in breast carcinoma: a valid tool to omit unnecessary axillary treatment or even more? Eur J Cancer 2004, 40:182-186.
37. Burak WE Jr, Walker MJ, Yee LD, Kim JA, Saha S, Hinkle G, Olsen JO, Pozderac R, Farrar WB: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999, 177:445-449.
38. Krynyckyi BR, Kim CK, Goyenechea MR, Chan PT, Zhang ZY, Machac J: Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas and analysis of images. Radiographics 2004, 24:121-145.
39. Pandey M, Deo SVS, Maharajan R: Fallacies of preoperative lymphoscintigraphy in detecting sentinel node in breast cancer. World J Surg Oncol 2005, 3:31.
40. Krynyckyi BR, Kim SC, Kim CK: Preoperative lymphoscintigraphy and triangulated patient body marking are important parts of the sentinel node process in breast cancer. World J Surg Oncol 2005, 3:56.
41. Kim SC, Kim DW, Moadel RM, Kim CK, Chatterjee S, Shafir MK, Travis A, Machac J, Krynyckyi BR: Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature. World J Surg Oncol 2005, 3:64.
42. Keshtgar MRS, Waddington WA, Lakhani SR, Ell PJ: The Sentinel Node in Surgical Oncology. Edited by Keshtgar MRS et al. Berlin, Heidelberg: Springer-Verlag; 1999.
43. Krynyckyi BR, Kim CK, Shafir MK, Mosci K, Machac J: Breast cancer and its management, the utility and technique of lymphoscintigraphy. In Nuclear Medicine Annual; Philadelphia. Edited by Freeman LM. Lippincott William & Wilkins; 2003: 131-169.
44. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, Buscombe J, Strauss HW, Paganelli G: Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001, 42:1198-1215.
45. Mariani G, Erba P, Villa G, Gipponi M, Manca G, Boni G, Buffoni F, Castagnola F, Paganelli G, Strauss HW: Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective. J Surg Oncol 2004, 85:112-122.
46. Bevilacqua JL, Gucciardo G, Cody HS, MacDonald KA, Sacchini V, Borgen PI, Van Zee KJ: A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer. Eur J Surg Oncol 2002, 28:603-614.
47. Tanis PJ, Nieweg OE, Valdes Olmos RA, Peterse JL, Rutgers EJ, Hoefnagel CA, Kroon BB: Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 2002, 87:705-710.
48. Estourgie SH, Tanis PJ, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Kroon BB: Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2003, 10:935-941.
49. Allweis TM, Parson B, Klein M, Sklair-Levy M, Maly B, Rivkind A, Uziely B: Breast cancer draining to bilateral axillary sentinel lymph nodes. Surgery 2003, 134:506-508.
50. Lim I, Shim J, Goyenechea M, Kim CK, Krynyckyi BR: Drainage across midline to sentinel nodes in the contralateral axilla in breast cancer. Clin Nucl Med 2004, 29:346-347.
51. Barranger E, Montravers F, Kerrou K, Marpeau O, Raileanu I, Antoine M, Talbot JN, Uzan S: Contralateral axillary sentinel lymph node drainage in breast cancer: A case report. J Surg Oncol 2004, 86:167-169.
52. Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Inoue T, Noguchi S: Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 2004, 100:2555-2561.
53. Carmon M, Mintz A, Hain D, Olsha O: Clinical implications of contralateral axillary sentinel lymph nodes. Breast 2005, [Epub ahead of print] DOI: 10.1016/j.breast.2005.03.007
54. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY: Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg 2004, 188:122-125.
55. Krynyckyi BR, Shim J, Goyenechea M, Kim CK: Layering of activity around a breast implant capsule during lymphoscintigraphy. Clin Nucl Med 2004, 29:598-599.
56. Munhoz AM, Aldrighi C, Buschpiegel C, Ono C, Montag E, Fells K, Arruda E, Sturtz G, Kovac P, Filassi JR, Gemperli R, Ferreira MC: The feasibility of sentinel lymph node detection in patients with previous transaxillary implant breast augmentation: preliminary results. Aesthetic Plast Surg 2005, 29:163-168.
57. Intra M, Trifiro G, Viale G, Rotmensz N, Gentilini OD, Soteldo J, Galimberti V, Veronesi P, Luini A, Paganelli G, Veronesi U: Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 2005, 12:1-5. DOI: 10.1245/ASO.2005.10.018
58. Morris KT, Stevens JS, Pommier RF, Fletcher WS, Vetto JT: Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanoma. Am J Surg 2001, 181:423-426.
59. Uren RF, Howman-Giles R, Thompson JF: Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003, 44:570-582.
60. Paepke S, Schwarz-Boeger U, Kiechle M, Jacobs VR: Axillary dissection with access minimized (ADAM): a new technique for lymph node dissection in conservative surgery for breast cancer. Int J Fertil Womens Med 2003, 48:232-237.
61. Ogawa Y, Ishikawa T, Sawada T, Chung SH, Osaka H, Takashima T, Onoda N, Kato Y, Ochi H, Hirakawa K: Thoracoscopic internal mammary sentinel node biopsy for breast cancer. Surg Endosc 2003, 17:315-319.
62. Singletary SE, Dowlatshahi K, Dooley W, Hollenbeck ST, Kern K, Kuerer H, Newman LA, Simmons R, Whitworth P: Minimally invasive operation for breast cancer. Curr Probl Surg 2004, 41:394-447.
63. Yamamoto D, Tanaka K: A review of mammary ductoscopy in breast cancer. Breast J 2004, 10:295-297.
64. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
65. Luini A, Zurrida S, Paganelli G, Galimberti V, Sacchini V, Monti S, Veronesi P, Viale G, Veronesi U: Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg 1999, 86:522-525.
66. Krynyckyi BR, Shafir M, Zhang Z, Kim CK, Machac J: TC-99M MAA improves on wire in localizing non-palpable breast lesions [abstract]. J Nuc Med 2004, 45:146P.
67. Pierini A, Dworkin HJ: Is the upright position more sensitive than the supine position in breast cancer sentinel node lymphoscintigraphy? Clin Nucl Med 2001, 26:823-825.
68. Uren RF, Howman-Giles R, Renwick SB, Gillett D: Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg 2001, 25:789-793.
69. Kim S, Youssef I, Kim CK, Machac J, Krynyckyi BR: Prominent lymphatic channels simulating sentinel nodes: The utility of standing and delayed views in delineating the true number and position of nodes and the implications for further morbidity reduction. Clin Nucl Med 2005, 30:794-796.
70. Kim SH, Kim SC, Kim DW, Kim YJ, Youssef IM, Kim CK, Machac J, Krynyckyi BR: Can different arm and body positions help in detecting more sentinel lymph nodes (SN) during lymphoscintigraphy (LS) [abstract]? J Nucl Med 2005, 46(supplement 2):405P.
71. Kim SH, Kim SC, Kim DW, Machac J, Kim CK, Krynyckyi BR: The effect of different arm positions on sentinel node localization during lymphoscintigraphy [abstract]. J Nucl Med 2005, 46(supplement 2):405P.
72. Krynyckyi BR, Kim CK, Mosci K, Fedorciw BJ, Zhang ZY, Lipszyc H, Machac J: Areolar-cutaneous "junction" injections to augment sentinel node count activity. Clin Nucl Med 2003, 28:97-107.
73. Cherry SR, Sorenson JA, Phelps ME: In Physics in Nuclear Medicine, third edition, Edited by W.B. Saunders, Philadelphia, PA; 2003:31-43; 65-88; 165-183.
74. Kim S, Kim CK, Krynyckyi BR: Areolar-cutaneous junction injection boosts activity in sentinel node by more than 50 times compared to perilesional injection: implications for morbidity reduction. Am Surg 2005, 71:77-80.
75. Yeung HW, Cody III HS, Turlakow A, Riedel ER, Fey J, Gonen M, Nunez R, Yeh SD, Larson SM: Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med 2001, 42:420-423.
76. Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KK: Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol 2001, 8:821-827.
77. Krynyckyi BR, Miner M, Ragonese JM, Firestone M, Kim CK, Machac J: Technical aspects of performing lymphoscintigraphy: Optimization of methods used to obtain images. Clin Nucl Med 2000, 25:978-985.
78. Kern KA: Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002, 195:467-475.
79. Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, Chung M, Watson M, Ota DM: Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 2004, 199:561-566.
80. Marrazzo A, Taormina P, Noto A, Cardinale G, Casa L, Mercadante S, Lo Gerfo D, David M: Localization of the sentinel lymph node in breast cancer: prospective comparison of vital staining and radioactive tracing methods. Chir Ital 2004, 56:621-627.
81. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-398.
82. Kern KA: Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999, 189:539-545.
83. Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F, Tomei D, Cafiero F, Moresco L, Nicolo G, Carli F, Villa G, Buffoni F, Badellino F: Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol 1998, 15:272-277.
84. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998, 227:645-651.
85. Bass SS, Lyman GH, McCann CR, Ku NN, Berman C, Durand K, Bolano M, Cox S, Salud C, Reintgen DS, Cox CE: Lymphatic Mapping and Sentinel Lymph Node Biopsy. Breast J 1999, 5:288-295.
86. King TA, Fey JV, Van Zee KJ, Heerdt AS, Gemignani ML, Port ER, Sclafani L, Sacchini V, Petrek JA, Cody HS 3rd, Borgen PI, Montgomery LL: A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 2004, 11:535-541.
87. Derossis AM, Fey J, Yeung H, Yeh SD, Heerdt AS, Petrek J, VanZee KJ, Montgomery LL, Borgen PI, Cody HS 3rd: A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001, 193:473-478.
88. Degnim AC, Oh K, Cimmino VM, Diehl KM, Chang AE, Newman LA, Sabel MS: Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol 2005, 12:712-717.
89. Krynyckyi BR, Firestone M, Eskandar Y, Kim CK, Machac J: Dual method injection technique for breast lymphoscintigraphy to maximize visualization of sentinel nodes [abstract]. J Nuc Med 2000, 41(supplement):281P.
90. Feezor RJ, Kasraeian A, Copeland EM 3rd, Schell SR, Hochwald SN, Cendan J, Drane W, Mastin S, Wilkinson E, Lind DS: Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience. Am Surg 2002, 68:684-688.
91. Singh-Ranger G, Mokbel K: Capsular contraction following immediate reconstructive surgery for breast cancer - An association with methylene blue dye. Int Semin Surg Oncol 2004, 1:3.
92. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Edwards MJ: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000, 231:724-731.
93. Dupont EL, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, Leight GS Jr, Ross MI, Blumencranz P, Reintgen DS; DOD Breast Lymphatic Mapping Trial Investigators: The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 2001, 8:354-360.
94. Merson M, Fenaroli P, Gianatti A, Virotta G, Giuliano LG, Bonasegale A, Bambina S, Pericotti S, Guerra U, Tondini C: Sentinel node biopsy in the surgical management of breast cancer: experience in a general hospital with a dedicated surgical team. Breast 2004, 13:200-205.
95. Trifiro G, Viale G, Gentilini O, Travaini LL, Paganelli G: Sentinel node detection in pre-operative axillary staging [abstract]. Eur J Nucl Med Mol Imaging 2004, 31(supplement 1):S46-55.
96. 57Co sources during breast lymphoscintigraphy by optimizing energy windows and other suggested enhancements of acquisition and the display of images. J Nucl Med Technol 2004, 32:198-205.
97. Tsushima H, Yamanaga T, Shimonishi Y, Ochi H: Usefulness of imaging method without using lead plate for sentinel lymph node scintigraphy. Kaku Igaku 2002, 39:161-169.
98. Kelley MC, Hansen N, McMasters KM: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg 2004, 188:49-61.
99. Tuttle TM: Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004, 70:407-413.
100. Scoggins CR, Chagpar AB, Martin RC, McMasters KM: Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nat Clin Pract Oncol 2005, 2:448-455.
101. Upponi SS, McIntosh SA, Wishart GC, Balan KK, Purushotham AD: Sentinel lymph node biopsy in breast cancer - is lymphoscintigraphy really necessary? Eur J Surg Oncol 2002, 28:479-480.
102. Chagpar AB, Kehdy F, Scoggins CR, Martin RC 2nd, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM; University of Louisville Breast Sentinel Lymph Node Study: Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005, 190:557-562.
103. Guenther JM, Collins JC, Barnes G Jr, O'Connell TX: Selective lymphoscintigraphy: a necessary adjunct to dye-directed sentinel node biopsy for breast cancer? Arch Surg 2000, 135:1101-1105.
104. McIntosh SA, Ravichandran D, Balan KK, Bobrow L, Wishart GC, Purushotham AD: Sentinel lymph node biopsy in impalpable breast cancer. Breast 2001, 10:82-83.
105. Purushotham AD, Macmillan RD, Wishart GC: Advances in axillary surgery for breast cancer-time for a tailored approach. Eur J Surg Oncol 2005, 31:929-931. doi: 10.1016/j.ejso.2005.07.008
106. Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS: Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 2004, 239:841-848.
107. Kim SH, Shim J, Kim CK, Machac J, Krynyckyi BR: Reverse echelon node and a lymphatic ectasia in the same patient during breast lymphoscintigraphy: The importance of injection and imaging technique. Br J Radiol 2004, 77:1053-1056.
108. Borgognoni L, Urso C, Vaggelli L, Brandani P, Gerlini G: Sentinel node detection in melanoma patients using computer-assisted gamma probe with adjustable collimation and specifically designed forceps. Oral presentation, International Sentinel Node Congress, Los Angeles, CA, December 3-6, 2004.
109. Pelosi E, Bello M, Giors M, Ala A, Giani R, Bussone R, Bisi G: Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 2004, 45:220-225.
110. Kern KA: Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid. J Am Coll Surg 2001, 193:601-608.
111. Uren RF, Thompson JF, Howman-Giles R. Sentinel nodes: Interval nodes, lymphatic lakes, and accurate sentinel node identification. Clin Nucl Med 2000, 25:234-236.
112. Tanis PJ, van Sandick JW, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Hoefnagel CA, Kroon BB: The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging 2002, 29:305-311.
113. Krynyckyi BR, Chun H, Kim HH, Eskandar Y, Kim CK, Machac J: Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy. J Nucl Med 2003, 44:1387-1393.
114. Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB: Lymphatic drainage patterns from the breast. Ann Surg 2004, 239:232-237.
115. Krynyckyi BR, Shim J, Kim CK: Internal mammary chain drainage of breast cancer [letter]. Ann Surg 2004, 240:557; author reply 558.
116. Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P: Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999, 188:248-254.
117. Keshtgar MR, Chicken DW, Waddington WA, Raven W, Ell PJ: A training simulator for sentinel node biopsy in breast cancer: a new standard. Eur J Surg Oncol 2005, 31:134-40.
118. Krynyckyi BR, Singh G, Colon D, Kim CK, Travis A, Kim SC, Machac J: Letter to the editor [letter]. Eur J Surg Oncol 2005, 31:805-806.
119. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004, 15:1348-1351.
120. Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuerer HM: The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004, 10:492-495.
121. Gennari R, Rotmensz N, Perego E, Santos GD, Veronesi U: Sentinel node biopsy in elderly breast cancer patients. Surg Oncol 2004, 13:193-196.
122. Kennedy RJ, Kollias J, Gill PG, Bochner M, Coventry BJ, Farshid G: Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 2003, 90:1349-1353.
123. Schrenk P, Rehberger W, Shamiyeh A, Wayand W: Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node? J Surg Oncol 2002, 80:130-136.
124. McMasters, KM, Wong SL, Chao C: Comment on the article "Highest isotope count does not predict sentinel node positivity in all breast cancer patients," by Martin et al., August 2001, Annals of Surgical Oncology [letter]. Ann Surg Oncol 2002, 9:317.
125. Camp ER, Cendan JC, Feezor R, Lind DS, Wilkinson E, Copeland EM: The hottest sentinel lymph node is not always the positive node. Am Surg 2004, 70:475-478.
126. Uren RF, Howman-Giles R, Chung D, Thompson JF: Nuclear medicine aspects of melanoma and breast lymphatic mapping. Semin Oncol 2004, 31:338-348.
127. Haigh PI, Hansen NM, Giuliano AE, Edwards GK, Ye W, Glass EC: Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 2000, 41:1682-1688.
128. Uren RF, Howman-Giles RB, Chung D, Thompson JF: Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treat Res 2005, 127:15-38.
129. Thompson JF, Uren RF, Scolyer RA, Stretch JR: Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treat Res 2005, 127:269-287.
130. Krynyckyi BR, Zhang ZY, Kim CK, Lipszyc H, Mosci K, Machac J: Effect of high specific-activity sulfur colloid preparations on sentinel node count rates. Clin Nucl Med 2002, 27:92-95.
131. Diaz NM, Vrcel V, Centeno BA, Muro-Cacho C: Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol 2005, 12:7-9.
132. Hampton T: Surgeons "vote with their feet" for sentinel node biopsy for breast cancer staging. JAMA 2003, 290:3053-3054.